Abstract
The purpose of this review is to describe and evaluate the antineoplastic properties of phenothiazines. The present research studies suggest that many phenothiazines do not show significant antitumor and antineoplastic activity and so they cannot be used as potential drugs to treat cancer. However some of their derivatives help indirectly in decreasing cytotoxic effects caused by radiation and other chemical carcinogens. Additionally, some phenothiazine derivatives provide protection against cancers caused by metabolic activation of carcinogens such as dimethylbenzanthracene. The selective accumulation of phenothiazine derivatives in certain tissues such as brain and melanoma tumors may provide an effective treatment of such tumors. Current studies suggest that highly potent phenothiazine derivatives can be made by nitro substitution on the aromatic ring of phenothiazines. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
| Original language | English |
|---|---|
| Pages (from-to) | 305-319 |
| Number of pages | 15 |
| Journal | Cancer Investigation |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1991 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Antitumor properties of phenothiazines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver